Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23043751

CCC#N.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
FAAH O00519 8/20 0.34
MCL1 Q07820 3/20 0.34
MLYCD O95822 1/20 0.34
CES1 P23141 5/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CTSS P25774 2/20 0.33
CTSK P43235 2/20 0.33
CES2 O00748 2/20 0.33
CYP1A2 P05177 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL27350364 1.00 ALDH1A1 (0.47) ALDH1A1FAAHMCL1MLYCDCES1
Trifluoroacetic Acid SCHEMBL27762565 0.83 TSHR (0.39) FAAHMLYCDCES1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL28697978 0.82 DPP4 (0.35) ALDH1A1FAAHMLYCDCES1MEN1
Trifluoroacetic Acid SCHEMBL6909668 0.80 FAAH (0.39) ALDH1A1FAAHCES1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL140346 0.80 ALDH1A1 (0.35) ALDH1A1DPP4DPP8
Trifluoroacetic Acid SCHEMBL4287600 0.80 ALDH1A1 (0.35) ALDH1A1DPP4DPP8
Trifluoroacetic Acid SCHEMBL5745817 0.80 ALDH1A1 (0.35) ALDH1A1DPP4DPP8
Trifluoroacetic Acid SCHEMBL128012 0.80 ALDH1A1 (0.35) ALDH1A1DPP4DPP8
Trifluoroacetic Acid SCHEMBL1727596 0.80 ALDH1A1 (0.35) ALDH1A1DPP4DPP8
Trifluoroacetic Acid SCHEMBL3833376 0.80 ALDH1A1 (0.35) ALDH1A1DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4021444-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2022-07-06 EP disclosed
WO-2021041671-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2021-03-04 WO disclosed